Moore C - Search Results

1

Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts.

Martin AM, Nolan D, James I, Cameron P, Keller J, Moore C, Phillips E, Christiansen FT, Mallal S. Martin AM, et al. Among authors: moore c. AIDS. 2005 Jan 3;19(1):97-9. doi: 10.1097/00002030-200501030-00014. AIDS. 2005. PMID: 15627041

2

Tumour necrosis factor-alpha gene -238G/A promoter polymorphism associated with a more rapid onset of lipodystrophy.

Nolan D, Moore C, Castley A, Sayer D, Mamotte C, John M, James I, Mallal S. Nolan D, et al. Among authors: moore c. AIDS. 2003 Jan 3;17(1):121-3. doi: 10.1097/00002030-200301030-00017. AIDS. 2003. PMID: 12478078 No abstract available.

3

Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.

Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA. Moore CB, et al. Science. 2002 May 24;296(5572):1439-43. doi: 10.1126/science.1069660. Science. 2002. PMID: 12029127 Free article.

4

Interactive selective pressures of HLA-restricted immune responses and antiretroviral drugs on HIV-1.

John M, Moore CB, James IR, Mallal SA. John M, et al. Antivir Ther. 2005;10(4):551-5. Antivir Ther. 2005. PMID: 16038481

5

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.

Mallal S, Nolan D, Witt C, Masel G, Martin AM, Moore C, Sayer D, Castley A, Mamotte C, Maxwell D, James I, Christiansen FT. Mallal S, et al. Among authors: moore c. Lancet. 2002 Mar 2;359(9308):727-32. doi: 10.1016/s0140-6736(02)07873-x. Lancet. 2002. PMID: 11888582

6

Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation.

Pace C, Keller J, Nolan D, James I, Gaudieri S, Moore C, Mallal S. Pace C, et al. Among authors: moore c. J Virol. 2006 Sep;80(18):9259-69. doi: 10.1128/JVI.00888-06. J Virol. 2006. PMID: 16940537 Free PMC article.

7

Interaction between allelic variation in IL12B and CCR5 affects the development of AIDS: IL12B/CCR5 interaction and HIV/AIDS.

Gabutero E, Moore C, Mallal S, Stewart G, Williamson P. Gabutero E, et al. Among authors: moore c. AIDS. 2007 Jan 2;21(1):65-9. doi: 10.1097/QAD.0b013e3280117f49. AIDS. 2007. PMID: 17148969

8

Randomized, controlled, 48-week study of switching stavudine and/or protease inhibitors to combivir/abacavir to prevent or reverse lipoatrophy in HIV-infected patients.

John M, McKinnon EJ, James IR, Nolan DA, Herrmann SE, Moore CB, White AJ, Mallal SA. John M, et al. J Acquir Immune Defic Syndr. 2003 May 1;33(1):29-33. doi: 10.1097/00126334-200305010-00005. J Acquir Immune Defic Syndr. 2003. PMID: 12792352 Clinical Trial.

9

Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression.

Gaudieri S, DeSantis D, McKinnon E, Moore C, Nolan D, Witt CS, Mallal SA, Christiansen FT. Gaudieri S, et al. Among authors: moore c. Genes Immun. 2005 Dec;6(8):683-90. doi: 10.1038/sj.gene.6364256. Genes Immun. 2005. PMID: 16121209

10

Periodontal attachment loss in HIV-infected patients is associated with the major histocompatibility complex 8.1 haplotype (HLA-A1,B8,DR3).

Price P, Calder DM, Witt CS, Allcock RJ, Christiansen FT, Davies GR, Cameron PU, Rogers M, Baluchova K, Moore CB, French MA. Price P, et al. Among authors: moore cb. Tissue Antigens. 1999 Oct;54(4):391-9. doi: 10.1034/j.1399-0039.1999.540409.x. Tissue Antigens. 1999. PMID: 10551423

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,356 results

Search Page

Filters